Imotopes: An immunotherapy animation of new immunotherapeutics



Imcyse is a clinical-stage biotech company created in 2010 as a spin-off of the Catholic University of Leuven, aiming to develop the next generation of therapeutic biologics.


At 3DforScience we turned the client illustrations into easily understandable 3D scientific animation explaining their disruptive approach through an immunotherapy animation.

Imcyse is developing a new class immunotherapeutic molecule: Imotopes. This new technology is the combination of target antigenic natural HLA-Class II peptidic epitopes with a specific thioredox motif.

As a result of this specific composition, the interaction between Imotopes and the antigen-specific T-cells induce lysis of a significant part of cells associated with the autoimmune response.

Therefore, these modified peptides successfully block the autoimmune response without affecting the other functions of the immune system. Thus, representing major progress for the treatment of autoimmune degenerative diseases such as type 1 diabetes, multiple sclerosis and rheumatoid arthritis.